Exelixis, Inc. (EXEL)
54.57
+0.49
(+0.91%)
USD |
NASDAQ |
Aug 24, 16:00
54.57
0.00 (0.00%)
After-Hours: 20:00
Exelixis Total Liabilities (Quarterly) : 650.47M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 650.47M |
| March 31, 2026 | 657.84M |
| December 31, 2025 | 720.71M |
| September 30, 2025 | 662.85M |
| June 30, 2025 | 644.54M |
| March 31, 2025 | 706.22M |
| December 31, 2024 | 742.77M |
| September 30, 2024 | 684.86M |
| June 30, 2024 | 653.39M |
| March 31, 2024 | 675.74M |
| December 31, 2023 | 732.49M |
| September 30, 2023 | 629.29M |
| June 30, 2023 | 614.53M |
| March 31, 2023 | 588.22M |
| December 31, 2022 | 583.06M |
| September 30, 2022 | 469.97M |
| June 30, 2022 | 490.14M |
| March 31, 2022 | 360.27M |
| December 31, 2021 | 405.62M |
| September 30, 2021 | 335.29M |
| June 30, 2021 | 324.19M |
| March 31, 2021 | 279.36M |
| December 31, 2020 | 268.39M |
| September 30, 2020 | 259.01M |
| June 30, 2020 | 213.22M |
| Date | Value |
|---|---|
| March 31, 2020 | 207.95M |
| December 31, 2019 | 208.94M |
| September 30, 2019 | 181.15M |
| June 30, 2019 | 154.47M |
| March 31, 2019 | 156.77M |
| December 31, 2018 | 136.11M |
| September 30, 2018 | 108.40M |
| June 30, 2018 | 136.19M |
| March 31, 2018 | 105.15M |
| December 31, 2017 | 370.33M |
| September 30, 2017 | 371.06M |
| June 30, 2017 | 368.02M |
| March 31, 2017 | 467.23M |
| December 31, 2016 | 508.22M |
| September 30, 2016 | 516.47M |
| June 30, 2016 | 663.27M |
| March 31, 2016 | 648.49M |
| December 31, 2015 | 474.53M |
| September 30, 2015 | 437.47M |
| June 30, 2015 | 436.97M |
| March 31, 2015 | 429.69M |
| December 31, 2014 | 442.79M |
| September 30, 2014 | 442.17M |
| June 30, 2014 | 437.39M |
| March 31, 2014 | 426.08M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Emergent BioSolutions, Inc. | 775.40M |
| Madrigal Pharmaceuticals, Inc. | 720.92M |
| United Therapeutics Corp. | 819.80M |
| AbbVie, Inc. | 141.00B |
| Tonix Pharmaceuticals Holding Corp. | 31.81M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.494B |
| Shareholders Equity (Quarterly) | 1.844B |
| Debt to Equity Ratio | 0.09 |
| Current Ratio | 3.456 |
| Net Debt Paydown Yield | 0.03% |